RU2005119303A - Композиция с модифицированным высвобождением, содержащая снотворное короткого действия для лечения нарушений сна - Google Patents
Композиция с модифицированным высвобождением, содержащая снотворное короткого действия для лечения нарушений сна Download PDFInfo
- Publication number
- RU2005119303A RU2005119303A RU2005119303/15A RU2005119303A RU2005119303A RU 2005119303 A RU2005119303 A RU 2005119303A RU 2005119303/15 A RU2005119303/15 A RU 2005119303/15A RU 2005119303 A RU2005119303 A RU 2005119303A RU 2005119303 A RU2005119303 A RU 2005119303A
- Authority
- RU
- Russia
- Prior art keywords
- aforementioned
- pharmaceutically acceptable
- core
- coating
- acceptable salt
- Prior art date
Links
- 208000019116 sleep disease Diseases 0.000 title claims 13
- 239000000203 mixture Substances 0.000 title claims 6
- 239000011248 coating agent Substances 0.000 claims 34
- 238000000576 coating method Methods 0.000 claims 34
- 239000002245 particle Substances 0.000 claims 34
- 150000003839 salts Chemical class 0.000 claims 27
- 229920000642 polymer Polymers 0.000 claims 25
- 239000008194 pharmaceutical composition Substances 0.000 claims 24
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 claims 24
- 229960004010 zaleplon Drugs 0.000 claims 24
- 238000000034 method Methods 0.000 claims 15
- 239000006187 pill Substances 0.000 claims 9
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 claims 8
- 239000003326 hypnotic agent Substances 0.000 claims 7
- 230000000147 hypnotic effect Effects 0.000 claims 7
- GBBSUAFBMRNDJC-MRXNPFEDSA-N (5R)-zopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-MRXNPFEDSA-N 0.000 claims 4
- UMSGKTJDUHERQW-UHFFFAOYSA-N Brotizolam Chemical compound C1=2C=C(Br)SC=2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl UMSGKTJDUHERQW-UHFFFAOYSA-N 0.000 claims 4
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 claims 4
- 229960003790 alimemazine Drugs 0.000 claims 4
- 229960003051 brotizolam Drugs 0.000 claims 4
- 229960003188 temazepam Drugs 0.000 claims 4
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 claims 4
- 229960003386 triazolam Drugs 0.000 claims 4
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 claims 4
- 229960001475 zolpidem Drugs 0.000 claims 4
- 229960000820 zopiclone Drugs 0.000 claims 4
- 230000001154 acute effect Effects 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000000977 initiatory effect Effects 0.000 claims 2
- 206010019133 Hangover Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42636902P | 2002-11-15 | 2002-11-15 | |
| US60/426,369 | 2002-11-15 | ||
| US10/704,633 | 2003-11-12 | ||
| US10/704,633 US20050038042A1 (en) | 2002-11-15 | 2003-11-12 | Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2005119303A true RU2005119303A (ru) | 2006-01-27 |
Family
ID=32329106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005119303/15A RU2005119303A (ru) | 2002-11-15 | 2003-11-14 | Композиция с модифицированным высвобождением, содержащая снотворное короткого действия для лечения нарушений сна |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050038042A1 (enExample) |
| EP (1) | EP1562560A1 (enExample) |
| JP (1) | JP2006512324A (enExample) |
| AU (1) | AU2003291715A1 (enExample) |
| RU (1) | RU2005119303A (enExample) |
| WO (1) | WO2004045589A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2384336C1 (ru) * | 2009-04-22 | 2010-03-20 | Маргарита Алексеевна Морозова | Фармацевтический состав для коррекции психосоматических проявлений |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL163548A0 (en) * | 2002-02-15 | 2005-12-18 | Biogal Pharmaceutical Co Ltd | Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom |
| EP2343073A3 (en) * | 2003-12-11 | 2011-10-12 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| US20050215521A1 (en) * | 2003-12-22 | 2005-09-29 | Karim Lalji | Modafinil combination therapy for improving sleep quality |
| EP1696959A2 (en) * | 2003-12-24 | 2006-09-06 | Sepracor, Inc. | Melatonin combination therapy for improving sleep quality |
| US7658945B2 (en) | 2004-02-17 | 2010-02-09 | Transcept Pharmaceuticals, Inc. | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| EP1742624B1 (en) * | 2004-02-18 | 2010-01-06 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| GB0423800D0 (en) | 2004-10-27 | 2004-12-01 | Orexo Ab | New pharmaceutical formulations |
| GB0423964D0 (en) * | 2004-10-28 | 2004-12-01 | Jagotec Ag | Dosage form |
| US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
| US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
| US20060276501A1 (en) * | 2005-05-25 | 2006-12-07 | Transoral Pharmaceuticals, Inc. | Solid compositions for treating middle-of-the-night insomnia |
| US20070020333A1 (en) * | 2005-07-20 | 2007-01-25 | Chin-Chih Chiang | Controlled release of hypnotic agents |
| TWI274889B (en) * | 2005-10-06 | 2007-03-01 | Elan Microelectronics Corp | Resistive touch screen measurement system |
| AR056633A1 (es) * | 2005-12-07 | 2007-10-17 | Gador Sa | Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones |
| US8309104B2 (en) * | 2006-03-02 | 2012-11-13 | Watson Pharmaceuticals, Inc. | Oral controlled release formulation for sedative and hypnotic agents |
| KR20070091960A (ko) * | 2006-03-08 | 2007-09-12 | 주식회사종근당 | 졸피뎀 또는 그의 염을 포함하는 안전한 제어방출형 제제조성물 |
| WO2007107878A2 (en) * | 2006-03-17 | 2007-09-27 | Aurobindo Pharma Limited | Solid dosage forms of hypnotic agent |
| US20070243252A1 (en) * | 2006-04-17 | 2007-10-18 | Actavis Group Ptc Hf | Oral Dosage Formulations and Methods of Preparing the Same |
| US20070243245A1 (en) * | 2006-04-17 | 2007-10-18 | Actavis Group Ptc Hf | Oral Dosage Formulations, Methods of Preparing the Same, and Methods of Reducing Food Effects on Drug Release |
| HUE029173T2 (hu) * | 2006-04-26 | 2017-02-28 | Alphapharm Pty Ltd | Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot |
| EP1970056A1 (en) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Time-specific delayed/pulsatile release dosage forms |
| WO2009006299A2 (en) * | 2007-06-29 | 2009-01-08 | Dr. Reddy's Laboratories Ltd. | Multi-particulate systems |
| WO2010064139A2 (en) * | 2008-12-04 | 2010-06-10 | Intec Pharma Ltd. | Zaleplon gastroretentive drug delivery system |
| CA2934595C (en) * | 2014-02-06 | 2022-06-21 | Sequential Medicine Limited | Composition and method for aiding sleep |
| WO2019071270A1 (en) * | 2017-10-06 | 2019-04-11 | Adare Pharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITIONS |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
| BR9802915A (pt) * | 1997-09-12 | 2000-01-11 | Oscar Gold | Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um) |
| CA2348871C (en) * | 1998-11-02 | 2009-04-14 | John G. Devane | Multiparticulate modified release composition |
| EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| WO2000059479A1 (en) * | 1999-04-06 | 2000-10-12 | Pharmaquest Ltd. | Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| US6485746B1 (en) * | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
| ATE241968T1 (de) * | 1999-08-26 | 2003-06-15 | Neurocrine Biosciences Inc | Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren |
-
2003
- 2003-11-12 US US10/704,633 patent/US20050038042A1/en not_active Abandoned
- 2003-11-14 JP JP2004553507A patent/JP2006512324A/ja active Pending
- 2003-11-14 EP EP03768607A patent/EP1562560A1/en not_active Withdrawn
- 2003-11-14 AU AU2003291715A patent/AU2003291715A1/en not_active Abandoned
- 2003-11-14 WO PCT/US2003/035046 patent/WO2004045589A1/en not_active Ceased
- 2003-11-14 RU RU2005119303/15A patent/RU2005119303A/ru not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2384336C1 (ru) * | 2009-04-22 | 2010-03-20 | Маргарита Алексеевна Морозова | Фармацевтический состав для коррекции психосоматических проявлений |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006512324A (ja) | 2006-04-13 |
| US20050038042A1 (en) | 2005-02-17 |
| EP1562560A1 (en) | 2005-08-17 |
| WO2004045589A1 (en) | 2004-06-03 |
| AU2003291715A1 (en) | 2004-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2005119303A (ru) | Композиция с модифицированным высвобождением, содержащая снотворное короткого действия для лечения нарушений сна | |
| JP2006512324A5 (enExample) | ||
| KR20060134041A (ko) | 음식물 섭취 관리 방법 | |
| JP2004537500A5 (enExample) | ||
| JP2004523513A (ja) | 活性化木炭に基づく組成物及びアルコール含有飲料の消費に関連する二日酔いを低減するための方法 | |
| JP2002053485A (ja) | アレルギー性疾患用医薬組成物 | |
| JP2004525940A5 (enExample) | ||
| JP2006504735A5 (ja) | 絨毛性性腺刺激ホルモンを含む慢性骨盤疼痛症候群の治療用組成物 | |
| CN107951764A (zh) | 一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| JP2001010977A (ja) | 経口用組成物 | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| JP2969509B2 (ja) | 催眠剤組成物 | |
| CN102824414B (zh) | 一种用于治疗便秘的药茶 | |
| CN107519152A (zh) | 一种口腔溃疡膜及其制备方法 | |
| CN103747791A (zh) | 蜂蜜与l-丙氨酰-l-谷氨酰胺的组合物 | |
| JPH10506097A (ja) | Ｊｅｔ ｌａｇを緩和するための方法と医薬 | |
| CN1220517C (zh) | 一种治疗胃肠疾病的药物 | |
| RU2120280C1 (ru) | Гомеопатическое средство "аценамет" для осуществления способа лечения алкогольной зависимости | |
| HUP0301451A3 (en) | Use of cgmp pde5 inhibitors for the preparation of pharmaceutical compositions treating peripheral vascular diseases, peripheral neuropathies and autonomic neuropathies | |
| CN102631497B (zh) | 一种保健组合物 | |
| WO2008021536A3 (en) | Use of interferon tau for the manufacture of a medicament in combination with interferon-alpha or interferon-beta for reduction of their adverse effects | |
| CN108261523A (zh) | 一种可治疗过敏性鼻炎的中药组合物及方法 | |
| CN102274160B (zh) | 用于治疗对抗高血压药的抗药性和相关病症的方法和制剂 | |
| CN106177269A (zh) | 速效治疗口腔黏膜疾病的药物组合物、制备方法及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20080905 |